Crystec Pharma
Pre-clinicalTransforming the performance of medicines through advanced particle engineering. CrystecPharma's proprietary mSAS® supercritical‑fluid platform improves bioavailability, stability and delivery of small and large molecule therapeutics.
Founded
2016
Focus
Drug Delivery
About
Transforming the performance of medicines through advanced particle engineering. CrystecPharma's proprietary mSAS® supercritical‑fluid platform improves bioavailability, stability and delivery of small and large molecule therapeutics.
Company Info
TypePrivate
Founded2016
LocationLondon, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile